{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:33:00Z","timestamp":1794918780960,"version":"4.9.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002958","name":"Tabriz University of Medical Sciences Drug Applied Research Center","doi-asserted-by":"publisher","award":["67932"],"award-info":[{"award-number":["67932"]}],"id":[{"id":"10.13039\/501100002958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.neuropharm.2024.110054","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T22:21:53Z","timestamp":1719699713000},"page":"110054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Investigating the therapeutic effects of nimodipine on vasogenic cerebral edema and blood-brain barrier impairment in an ischemic stroke rat model"],"prefix":"10.1016","volume":"257","author":[{"given":"Javad","family":"Shadman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3315-7624","authenticated-orcid":false,"given":"Hamdollah","family":"Panahpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6484-4267","authenticated-orcid":false,"given":"Mohammad Reza","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3026-6398","authenticated-orcid":false,"given":"Ahmad","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Shahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saied Salimpour","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/187152708784936608","article-title":"Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies","volume":"7","author":"Adibhatla","year":"2008","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110054_bib2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.STR.31.6.1250","article-title":"Effect of intravenous nimodipine on blood pressure and outcome after acute stroke","volume":"31","author":"Ahmed","year":"2000","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1046\/j.1471-4159.1999.0731189.x","article-title":"Mitochondrial respiratory function and cell death in focal cerebral ischemia","volume":"73","author":"Anderson","year":"1999","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110054_bib4","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1111\/ene.14985","article-title":"Blood\u2013brain barrier leakage and hemorrhagic transformation: the Reperfusion Injury in Ischemic StroKe (RISK) study","volume":"28","author":"Arba","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110054_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.594613","article-title":"Blood\u2013brain barrier disruption and hemorrhagic transformation in acute ischemic stroke: systematic review and meta-analysis","volume":"11","author":"Arba","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110054_bib6","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s11064-018-2569-9","article-title":"Irisin peptide protects brain against ischemic injury through reducing apoptosis and enhancing BDNF in a rodent model of stroke","volume":"43","author":"Asadi","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2024.110054_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuropharm.2012.10.004","article-title":"Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF\/TrkB\/Erk1\/2 signaling in neuroprotection","volume":"67","author":"Atif","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijdevneu.2010.08.001","article-title":"Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics","volume":"29","author":"Babu","year":"2011","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110054_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01452","article-title":"The neurovascular unit: effects of brain insults during the perinatal period","volume":"13","author":"Bell","year":"2020","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib10","first-page":"58","article-title":"Regulation of calcium homeostasis in microglia: current View on the pathogenesis and Correction of neuroinflammation","volume":"10","author":"Berdnikov","year":"2023","journal-title":"Opera Medica et Physiologica"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110054_bib11","first-page":"1067","article-title":"Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results","volume":"25","author":"Biondi","year":"2004","journal-title":"Am. J. Neuroradiol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110054_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000321965","article-title":"Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome","volume":"65","author":"Brouns","year":"2011","journal-title":"Eur. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1570159X17666190927113021","article-title":"Nimodipine reappraised: an old drug with a future","volume":"18","author":"Carlson","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10409230701340019","article-title":"The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases","volume":"42","author":"Cauwe","year":"2007","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2024.110054_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12035-013-8538-z","article-title":"Mmp-9 inhibition: a therapeutic strategy in ischemic stroke","volume":"49","author":"Chaturvedi","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110054_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12035-013-8486-7","article-title":"Temporal regulation of apoptotic and anti-apoptotic molecules after middle cerebral artery occlusion followed by reperfusion","volume":"49","author":"Chelluboina","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.STR.30.3.662","article-title":"Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats","volume":"30","author":"Colbourne","year":"1999","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110054_bib19","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1460-9568.2005.04367.x","article-title":"Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice","volume":"22","author":"Copin","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110054_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jnen\/62.2.127","article-title":"Inflammatory mechanisms after ischemia and stroke","volume":"62","author":"Danton","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.2010.05761.x","article-title":"Acute anti\u2010inflammatory approaches to ischemic stroke","volume":"1207","author":"Del Zoppo","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2010.05760.x","article-title":"The neurovascular unit, matrix proteases, and innate inflammation","volume":"1207","author":"Del Zoppo","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2024.110054_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00540","article-title":"The inflammatory response after ischemic stroke: targeting \u03b22 and \u03b21 integrins","volume":"13","author":"Edwards","year":"2019","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110054_bib24","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1152\/jn.00638.2020","article-title":"Blood-brain barrier dysfunction in hemorrhagic transformation: a therapeutic opportunity for nanoparticles and melatonin","volume":"125","author":"Figueroa","year":"2021","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1600-0404.2003.00202.x","article-title":"Blood pressure, nimodipine, and outcome of ischemic stroke","volume":"109","author":"Fogelholm","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2024.110054_bib26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fncel.2019.00098","article-title":"Calcium dynamics in dendrites of hippocampal CA1 interneurons in awake mice","volume":"13","author":"Francavilla","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110054_bib27","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/STROKEAHA.108.534503","article-title":"Temporal and spatial dynamics of cerebral immune cell accumulation in stroke","volume":"40","author":"Gelderblom","year":"2009","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110054_bib28","doi-asserted-by":"crossref","first-page":"H558","DOI":"10.1152\/ajpheart.01275.2004","article-title":"Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia","volume":"289","author":"Gidday","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110054_bib29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/13543784.14.5.579","article-title":"Voltage-gated cation channel modulators for the treatment of stroke","volume":"14","author":"Gribkoff","year":"2005","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"9834","key":"10.1016\/j.neuropharm.2024.110054_bib30","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial","volume":"379","author":"Group","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2024.110054_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.988283","article-title":"Cerebral edema after ischemic stroke: pathophysiology and underlying mechanisms","volume":"16","author":"Gu","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110054_bib32","article-title":"Ischemic brain edema: Emerging cellular mechanisms and therapeutic approaches","volume":"106029","author":"Han","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110054_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2019.11.005","article-title":"Mitochondria as a therapeutic target for ischemic stroke","volume":"146","author":"He","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110054_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.STR.32.2.461","article-title":"Very early nimodipine use in Stroke (VENUS) A randomized, double-blind, placebo-controlled Trial","volume":"32","author":"Horn","year":"2001","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.surneu.2005.12.028","article-title":"Inflammation in stroke and focal cerebral ischemia","volume":"66","author":"Huang","year":"2006","journal-title":"Surg. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneumeth.2012.12.005","article-title":"A simple method for isolating rat brain mitochondria with high metabolic activity: effects of EDTA and EGTA","volume":"213","author":"Iglesias-Gonz\u00e1lez","year":"2013","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2024.110054_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pneurobio.2017.10.001","article-title":"Blood-brain barrier dysfunction and recovery after ischemic stroke","volume":"163","author":"Jiang","year":"2018","journal-title":"Progress in neurobiology"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110054_bib38","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/STROKEAHA.107.505420","article-title":"Early disruption of the blood\u2013brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke","volume":"39","author":"Kastrup","year":"2008","journal-title":"Stroke"},{"issue":"25","key":"10.1016\/j.neuropharm.2024.110054_bib39","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1016\/j.lfs.2003.06.014","article-title":"Effect of losartan on the blood\u2013brain barrier permeability in diabetic hypertensive rats","volume":"73","author":"Kaya","year":"2003","journal-title":"Life Sci."},{"issue":"21","key":"10.1016\/j.neuropharm.2024.110054_bib40","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1111\/febs.13412","article-title":"The dynamic blood\u2013brain barrier","volume":"282","author":"Keaney","year":"2015","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/STROKEAHA.107.488189","article-title":"Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study","volume":"39","author":"Kelly","year":"2008","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110054_bib42","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/tox.22947","article-title":"Chrysin ameliorates aluminum p hosphide\u2010induced oxidative stress and mitochondrial damages in rat cardiomyocytes and isolated mitochondria","volume":"35","author":"Khezri","year":"2020","journal-title":"Environ. Toxicol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110054_bib43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110054_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-7-97","article-title":"Inflammatory mechanisms in ischemic stroke: therapeutic approaches","volume":"7","author":"Lakhan","year":"2009","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuropharm.2024.110054_bib45","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-198937050-00004","article-title":"Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease","volume":"37","author":"Langley","year":"1989","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110054_bib46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/01.WCB.0000122747.72175.47","article-title":"Induction of Caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after Hypoxia\u2014Reoxygenation","volume":"24","author":"Lee","year":"2004","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1523\/JNEUROSCI.4243-03.2004","article-title":"Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.neuropharm.2008.10.016","article-title":"Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation","volume":"56","author":"Li","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110054_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1349369","article-title":"Blood-brain barrier disruption and hemorrhagic transformation in acute stroke before endovascular reperfusion therapy","volume":"15","author":"Liang","year":"2024","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110054_bib50","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/00001756-200107030-00034","article-title":"Association of immune responses and ischemic brain infarction in rat","volume":"12","author":"Liao","year":"2001","journal-title":"Neuroreport"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110054_bib51","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41401-020-0409-3","article-title":"Icariside II attenuates cerebral ischemia\/reperfusion-induced blood\u2013brain barrier dysfunction in rats via regulating the balance of MMP9\/TIMP1","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110054_bib52","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.STR.29.8.1679","article-title":"Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and improves neurological outcome","volume":"29","author":"Liu","year":"1998","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1871527320666210212141232","article-title":"Role of calcium homeostasis in ischemic stroke: a review","volume":"21","author":"Ludhiadch","year":"2022","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110054_bib55","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.STR.21.7.1023","article-title":"Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction","volume":"21","author":"Martinez-Vila","year":"1990","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib56","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/jbc.R116.760215","article-title":"The translational significance of the neurovascular unit","volume":"292","author":"McConnell","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110054_bib57","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/1440-1681.13328","article-title":"1, 25\u2010dihydroxyvitamin D3 prevents deleterious effects of erythromycin on mitochondrial function in rat heart isolated mitochondria","volume":"47","author":"Mersa","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archneurpsyc.1954.02330030030003","article-title":"Polarographic study of cerebral collateral circulation","volume":"72","author":"Meyer","year":"1954","journal-title":"AMA Archives of Neurology & Psychiatry"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110054_bib59","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1248\/bpb.b16-00991","article-title":"Protection of the blood\u2013brain barrier as a therapeutic strategy for brain damage","volume":"40","author":"Michinaga","year":"2017","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110054_bib60","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1471-4906(03)00117-0","article-title":"Leukocyte\u2013endothelial-cell interactions in leukocyte transmigration and the inflammatory response","volume":"24","author":"Muller","year":"2003","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1523\/JNEUROSCI.18-01-00205.1998","article-title":"Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency","volume":"18","author":"Murakami","year":"1998","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110054_bib62","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1046\/j.1471-4159.1995.65062432.x","article-title":"Bcl\u20102 protects neural cells from cyanide\/aglycemia\u2010induced lipid oxidation, mitochondrial injury, and loss of viability","volume":"65","author":"Myers","year":"1995","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110054_bib63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/RLI.0000000000000539","article-title":"Futile recanalization with poor clinical outcome is associated with increased edema volume after ischemic stroke","volume":"54","author":"Nawabi","year":"2019","journal-title":"Invest. Radiol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110054_bib64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/neuros\/nyx357","article-title":"Neurovascular unit: basic and clinical imaging with emphasis on advantages of ferumoxytol","volume":"82","author":"Netto","year":"2018","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib65","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.2000.80.1.315","article-title":"Mitochondria and neuronal survival","volume":"80","author":"Nicholls","year":"2000","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib66","first-page":"12","article-title":"Inhibition of angiotensin-converting enzyme reduces cerebral infarction size in experimental-induced focal cerebral ischemia in the rat","volume":"32","author":"Panahpour","year":"2007","journal-title":"Iran. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib67","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.410290302","article-title":"Cerebral hemodynamics in ischemic cerebrovascular disease","volume":"29","author":"Powers","year":"1991","journal-title":"Ann. Neurol.: Official Journal of the American Neurological Association and the Child Neurology Society"},{"key":"10.1016\/j.neuropharm.2024.110054_bib68","article-title":"Exploring the intricacies of calcium dysregulation in ischemic stroke: Insights into neuronal cell death and therapeutic strategies","volume":"122651","author":"Rahi","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib69","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1038\/s41467-020-17930-x","article-title":"Blood substitution therapy rescues the brain of mice from ischemic damage","volume":"11","author":"Ren","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib70","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/07357907.2016.1276187","article-title":"Chrysin as an anti-cancer agent exerts selective toxicity by directly inhibiting mitochondrial complex II and V in CLL B-lymphocytes","volume":"35","author":"Salimi","year":"2017","journal-title":"Cancer Invest."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110054_bib71","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1060028018778751","article-title":"Impact of early versus late intravenous followed by oral nimodipine treatment on the occurrence of delayed cerebral ischemia among patients with aneurysm subarachnoid hemorrhage","volume":"52","author":"Samseethong","year":"2018","journal-title":"Ann. Pharmacother."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110054_bib72","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/s41593-021-00904-7","article-title":"Revisiting the neurovascular unit","volume":"24","author":"Schaeffer","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110054_bib73","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110054_bib74","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1096\/fasebj.3.7.2565839","article-title":"Pharmacological basis for the use of nimodipine in central nervous system disorders","volume":"3","author":"Scriabine","year":"1989","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2024.110054_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113125","article-title":"Glutamate excitotoxicity: potential therapeutic target for ischemic stroke","volume":"151","author":"Shen","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110054_bib76","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1208\/s12248-017-0091-7","article-title":"Blood-brain barrier protection as a therapeutic strategy for acute ischemic stroke","volume":"19","author":"Sifat","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2024.110054_bib77","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuint.2016.07.003","article-title":"Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinsonism in mice","volume":"99","author":"Singh","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2024.110054_bib78","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12291-019-00838-9","article-title":"Modes of calcium regulation in ischemic neuron","volume":"34","author":"Singh","year":"2019","journal-title":"Indian J. Clin. Biochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib79","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0271678X15617172","article-title":"Molecular pathophysiology of cerebral edema","volume":"36","author":"Stokum","year":"2016","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110054_bib80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41984-023-00191-3","article-title":"Role of endovascular super selective intra-arterial injection of CA channel blocker agent (nimodipine) in management of cerebral vasospasm following aneurysmal SAH: a single institution experience","volume":"38","author":"Sultan","year":"2023","journal-title":"Egyptian Journal of Neurosurgery"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110054_bib81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ceca.2010.01.003","article-title":"Calcium, ischemia and excitotoxicity","volume":"47","author":"Szydlowska","year":"2010","journal-title":"Cell Calcium"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110054_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0031-9384(00)00221-3","article-title":"Nimodipine improves the disruption of spatial cognition induced by cerebral ischemia","volume":"70","author":"Taya","year":"2000","journal-title":"Physiology & behavior"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neulet.2008.07.033","article-title":"ND-309, a novel compound, ameliorates cerebral infarction in rats by antioxidant action","volume":"442","author":"Tian","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110054_bib84","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/10641960802580232","article-title":"Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies","volume":"30","author":"Tomassoni","year":"2008","journal-title":"Clinical and experimental hypertension"},{"key":"10.1016\/j.neuropharm.2024.110054_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107850","article-title":"Chitosan nanoparticles release nimodipine in response to tissue acidosis to attenuate spreading depolarization evoked during forebrain ischemia","volume":"162","author":"T\u00f3th","year":"2020","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110054_bib86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ilar.44.2.85","article-title":"Animal models of focal and global cerebral ischemia","volume":"44","author":"Traystman","year":"2003","journal-title":"ILAR J."},{"key":"10.1016\/j.neuropharm.2024.110054_bib87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jnc.13415","article-title":"MMP\u20109 in translation: from molecule to brain physiology, pathology, and therapy","volume":"139","author":"Vafadari","year":"2016","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110054_bib88","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3171\/JNS\/2008\/109\/8\/0287","article-title":"Aggravation of infarct formation by brain swelling in a large territorial stroke: a target for neuroprotection?","volume":"109","author":"Walberer","year":"2008","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2024.110054_bib89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clineuro.2014.09.012","article-title":"The function of aquaporin4 in ischemic brain edema","volume":"127","author":"Wang","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neuropharm.2024.110054_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154034","article-title":"Guhong injection promotes post-stroke functional recovery via attenuating cortical inflammation and apoptosis in subacute stage of ischemic stroke","volume":"99","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110054_bib91","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/156802609788317838","article-title":"Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke","volume":"9","author":"Yamamoto","year":"2009","journal-title":"Current topics in medicinal chemistry"},{"key":"10.1016\/j.neuropharm.2024.110054_bib92","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s12975-019-00758-z","article-title":"Selective mGluR1 negative allosteric modulator reduces blood\u2013brain barrier permeability and cerebral edema after experimental subarachnoid hemorrhage","volume":"11","author":"Zhang","year":"2020","journal-title":"Translational stroke research"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/00207454.2014.919916","article-title":"Association between intercellular adhesion molecule-1 gene K469E polymorphism and the risk of stroke in a Chinese population: a meta-analysis","volume":"125","author":"Zhang","year":"2015","journal-title":"Int. J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110054_bib94","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0006-8993(95)00346-R","article-title":"The temporal profiles of ICAM-1 protein and mRNA expression after transient MCA occlusion in the rat","volume":"682","author":"Zhang","year":"1995","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110054_bib95","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/147323001204000322","article-title":"Nimodipine improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia","volume":"40","author":"Zhang","year":"2012","journal-title":"J. Int. Med. Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110054_bib96","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nm1387","article-title":"Role of matrix metalloproteinases in delayed cortical responses after stroke","volume":"12","author":"Zhao","year":"2006","journal-title":"Nature medicine"},{"key":"10.1016\/j.neuropharm.2024.110054_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.147937","article-title":"Factors influencing the blood-brain barrier permeability","volume":"1788","author":"Zhao","year":"2022","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110054_bib98","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jinorgbio.2009.11.007","article-title":"Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress","volume":"104","author":"Zhao","year":"2010","journal-title":"J. Inorg. Biochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110054_bib99","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.scib.2018.12.006","article-title":"The efficacy and safety of nimodipine in acute ischemic stroke patients with mild cognitive impairment: a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Zheng","year":"2019","journal-title":"Sci. Bull."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T22:12:50Z","timestamp":1723587170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824002235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":99,"alternative-id":["S0028390824002235"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110054","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the therapeutic effects of nimodipine on vasogenic cerebral edema and blood-brain barrier impairment in an ischemic stroke rat model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110054"}}